Sanofi is closer to selling a 50% controlling stake in the consumer health business, Opella to private equity Clayton Dublilier & Rice, known as CD&R. The two companies shared that they have ...

Today, a brief rundown of news involving Sanofi and Supernus Pharmaceuticals, as well as updates from Arcus Biosciences, Gilead Sciences and Ultragenyx Pharmaceutical that you might have missed. Seven ...

NEW YORK, Feb. 12, 2025 /PRNewswire/ -- CD&R (or the "Firm") today announced the appointment of former Charles Schwab CFO Peter Crawford as an Operating Advisor to CD&R funds. Peter will play an ...

NEW YORK, Feb. 5, 2025 /PRNewswire/ -- CD&R (or the "Firm") announced today the appointment of Sam Camens as Managing Director. Sam will drive CD&R's health and welfare strategy, including ...